AbbVie Inc. Files 8-K on Financials and Debt
Ticker: ABBV · Form: 8-K · Filed: 2025-01-31T00:00:00.000Z
Sentiment: neutral
Topics: financial-condition, debt, filing
Related Tickers: ABBV
TL;DR
AbbVie dropped its 8-K on Jan 31, 2025 - check out the debt details!
AI Summary
On January 31, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes, such as the Sec0.750 Senior Notes Due 2027 and Sec2.125 Senior Notes Due 2028, indicating ongoing financial activities and debt management.
Why It Matters
This filing provides investors with crucial updates on AbbVie's financial health and its outstanding debt instruments, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- AbbVie Inc. (company) — Filer of the 8-K report
- January 31, 2025 (date) — Date of the earliest event reported
- Sec0.750 Senior Notes Due 2027 (dollar_amount) — Specific debt instrument mentioned
- Sec2.125 Senior Notes Due 2028 (dollar_amount) — Specific debt instrument mentioned
FAQ
What is the primary purpose of this 8-K filing by AbbVie Inc.?
The primary purpose of this 8-K filing is to report on AbbVie Inc.'s results of operations and financial condition, as well as to include financial statements and exhibits.
What is the filing date for this 8-K report?
The 8-K report was filed as of January 31, 2025.
Which specific senior notes are mentioned in the filing details?
The filing details mention several senior notes, including Sec0.750 Senior Notes Due 2027, Sec2.125 Senior Notes Due 2028, Sec2625 Senior Notes Due 2028, Sec2125 Senior Notes Due 2029, and Sec1250 Senior Notes Due 2031.
What is AbbVie Inc.'s Standard Industrial Classification (SIC) code?
AbbVie Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Where is AbbVie Inc. headquartered?
AbbVie Inc. is headquartered in North Chicago, Illinois, with its business and mail address listed as 1 North Waukegan Road, North Chicago, IL 60064.
From the Filing
0001551152-25-000011.txt : 20250131 0001551152-25-000011.hdr.sgml : 20250131 20250131074237 ACCESSION NUMBER: 0001551152-25-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250131 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250131 DATE AS OF CHANGE: 20250131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 25575942 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 8-K 1 abbv-20250131.htm 8-K abbv-20250131 0001551152 false 0001551152 2025-01-31 2025-01-31 0001551152 exch:XCHI us-gaap:CommonStockMember 2025-01-31 2025-01-31 0001551152 exch:XNYS us-gaap:CommonStockMember 2025-01-31 2025-01-31 0001551152 exch:XNYS abbv:Sec0.750SeniorNotesDue2027Member 2025-01-31 2025-01-31 0001551152 exch:XNYS abbv:Sec2.125SeniorNotesdue2028Member 2025-01-31 2025-01-31 0001551152 exch:XNYS abbv:Sec2625SeniorNotesDue2028Member 2025-01-31 2025-01-31 0001551152 exch:XNYS abbv:Sec2125SeniorNotesDue2029Member 2025-01-31 2025-01-31 0001551152 exch:XNYS abbv:Sec1250SeniorNotesDue2031Member 2025-01-31 2025-01-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _____________________________________________________ FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 31, 2025   ABBVIE INC. (Exact name of registrant as specified in its charter) Delaware   001-35565   32-0375147 (State or other jurisdiction   (Commission File Number)   (IRS Employer of incorporation)       Identification No.)  _____________________________________________________ 1 North Waukegan Road North Chicago ,  Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 847 ) 932-7900   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐                        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐                       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐                        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐                        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange Chicago Stock Exchange 0.750% Senior Notes due 2027 ABBV27 New York Stock Exchange 2.125% Senior Notes due 2028 ABBV28 New York Stock Exchange 2.625% Senior Notes due 2028